Delivery Order SPE2DB20D3101-SPE2DB23FRFU2

Award Date 3/21/23
Potential Completion Date 3/22/23
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $3,557.69, is for the supply of 60 units of Cyclosporine 0.05% eye emulsion, a medication used to treat eye conditions. The order is a firm fixed-price contract with a performance period ending on November 3, 2023. This order is part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% Eye Emulsion. The contract has a firm fixed price of $1,826.61 and an ultimate completion date of October 16, 2024. This award is not set aside for any specific business type. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,584.83, is for the supply of Cyclosporine 0.05% eye emulsion. The contract is a firm fixed-price type, with a period of performance through January 18, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,277.60 firm-fixed-price contract is for the supply of Cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product. The contract is part of Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The contract is a firm-fixed-price delivery order worth $2,969.72, with a period of performance through September 27, 2024. AmerisourceBergen is the prime contractor and there is no set-aside designation mentioned. This order is likely part of a larger Indefinite Delivery Contract (IDC) between...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,970.36, is for the supply of Cyclosporine 0.05% eye emulsion, which is a critical pharmaceutical product used in the treatment of various eye conditions. The contract has an ultimate completion date of January 15, 2025 and is part of a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for $1,152.00 and covers the delivery of 4566948133 - Cyclosporine 0.05% Eye Emulsion 30s. The contract has a firm fixed price pricing type and an ultimate completion date of January 16, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The contract has a ceiling value of $4,820.52 and is a firm fixed-price delivery order, with a period of performance through December 23, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The $2,181.63 contract has an ultimate completion date of December 5, 2022 and is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of pharmaceuticals and medical supplies to support military...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cyclosporine 0.05% eye emulsion, a specialty medication. The contract has a ceiling value of $5,621.71 and a completion date of December 5, 2024. It is a Firm Fixed Price contract, which indicates a predetermined price for the goods or services. The contract was not set aside for any...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRFU2
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,990.61, is for the delivery of Cyclosporine 0.05% eye emulsion, a medication used to treat various eye conditions.

The contract is a firm fixed-price type with a period of performance through March 22, 2023. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen, as the prime contractor, will be responsible for supplying this pharmaceutical product to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions served by the DLA. The contract is a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense and other federal agencies.

Generated 2/27/25, 11:29 AM